In this study, the cross-tissue integration analysis of paired tumor and lymph node scRNA/TCR-seq data showed that the activated tumor-cytotoxic CD8+ T cells were mainly differentiated from progenitor-exhausted CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.